nach oben

Erschienen in:

12.06.2020 | COVID-19 | Hot Topic Zur Zeit gratis

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

verfasst von: Madan Raj Aryal, Rohit Gosain, Anthony Donato, Ranjan Pathak, Vijaya Raj Bhatt, Anjan Katel, Peter Kouides

Erschienen in: Current Cardiology Reports | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients.

Recent Findings

In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients.

Summary

Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.

Obi AT, Tignanelli CJ, Jacobs BN, Arya S, Park PK, Wakefield TW, et al. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. J Vasc Surg Venous Lymphat Disord. 2019;7(3):317–24. https://doi.org/10.1016/j.jvsv.2018.08.010.

Chen Y-G, Lin T-Y, Huang W-Y, Lin C-L, Dai M-S, Kao C-H. Association between pneumococcal pneumonia and venous thromboembolism in hospitalized patients: a nationwide population-based study. Respirol Carlton Vic. 2015;20(5):799–804. https://doi.org/10.1111/resp.12501.CrossRef

Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost JTH Published online April. 2020;9:1421–4. https://doi.org/10.1111/jth.14830.

Klok FA, Kruip MJHA, Meer NJM van der, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;0(0). doi:https://doi.org/10.1016/j.thromres.2020.04.013

Shi C, Wang C, Wang H, et al. The potential of low molecular weight heparin to mitigate cytokine storm in severe covid-19 patients: a retrospective clinical study. medRxiv. Published online April 7, 2020:2020.03.28.20046144. doi:https://doi.org/10.1101/2020.03.28.20046144

Campbell CM, Kahwash R. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? Circulation Published online April. 2020;9:1739–41. https://doi.org/10.1161/CIRCULATIONAHA.120.047419.

Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;0(0):null. doi:https://doi.org/10.1056/NEJMc2007575

Chaturvedi S, Braunstein EM, Yuan X, Yu J, Alexander A, Chen H, et al. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood. 2020;135(4):239–51. https://doi.org/10.1182/blood.2019003863.

Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb Haemost JTH. 2016;14(6):1308–13. https://doi.org/10.1111/jth.13323.CrossRefPubMed

10.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost JTH Published online March. 2020;27:1094–9. https://doi.org/10.1111/jth.14817.

11.

Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis Published online April. 2020;3. https://doi.org/10.1007/s11239-020-02105-8.

12.

Helms J, Tacquard C, Francois Severac. High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study. doi:https://doi.org/10.1007/s00134-020-06062-x

13.

Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020;0(0). doi:https://doi.org/10.1016/S2352-3026(20)30109-5

14.

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol Published online April. 2020;15. https://doi.org/10.1016/j.jacc.2020.04.031.

15.

Casini A, Alberio L, Angelillo-Scherrer A, Fontana P, Gerber B, Graf L, et al. Thromboprophylaxis and laboratory monitoring for in-hospital patients with Covid-19 - a Swiss consensus statement by the Working Party Hemostasis. Swiss Med Wkly. 2020;150:w20247. https://doi.org/10.4414/smw.2020.20247.

16.

Coronavirus. Accessed April 12, 2020. https://www.england.nhs.uk/coronavirus/

17.

Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, et al. Extended thromboprophylaxis with betrixaban in acutely ill medical patients. N Engl J Med. 2016;375(6):534–44. https://doi.org/10.1056/NEJMoa1601747.

18.

COVID-19 and pulmonary embolism - Hematology.org. Accessed April 12, 2020. https://www.hematology.org:443/covid-19/covid-19-and-pulmonary-embolism

19.

Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med. 2013;368(6):513–23. https://doi.org/10.1056/NEJMoa1111096.

Titel: Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
verfasst von: Madan Raj Aryal
Rohit Gosain
Anthony Donato
Ranjan Pathak
Vijaya Raj Bhatt
Anjan Katel
Peter Kouides
Publikationsdatum: 12.06.2020
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Current Cardiology Reports / Ausgabe 7/2020
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-020-01327-9

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment